(VIANEWS) – ELKEM (ELK.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Basic Materials sector.
| Financial Asset | Price | Forward Dividend Yield | Return on Equity |
|---|---|---|---|
| ELKEM (ELK.OL) | kr16.52 | 25.91% | 19.37% |
| IMCD (IMCD.AS) | €111.55 | 2.15% | 17.66% |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. ELKEM (ELK.OL)
25.91% Forward Dividend Yield and 19.37% Return On Equity
Elkem ASA provides silicones, silicon products, and carbon solutions worldwide. The company offers silicones polymers, including chlorosilanes and silicone oils; silicone elastomers, comprising liquid silicone rubber, heat cured rubber, and RTV-1 and RTV-2 silicones; and silicone fluids, such as silicone resin, silicone compounds, silicone grease, and silicone emulsion. It also provides silicon based materials comprising silicon, silicon powder/micronized silicon, silica fume/ microsilica, ferrosilicon, grain refiner, silicon and boron carbide, ferrosilicon nitride, fused silica, polymer additives, and specialties for refractories. In addition, the company offers foundry alloys, such as foundry alloys, preconditioners, recarburizers, conditioners, nodularizers, inserts, and inoculants; and carbon based materials comprising furnace tapping materials, cathode ramming paste, furnace lining materials, electrode paste, and prebaked and other electrodes. The company was founded in 1904 and is headquartered in Oslo, Norway. Elkem ASA is a subsidiary of Bluestar Elkem International Co., Ltd. S.A.
Earnings Per Share
As for profitability, ELKEM has a trailing twelve months EPS of kr7.76.
PE Ratio
ELKEM has a trailing twelve months price to earnings ratio of 2.13. Meaning, the purchaser of the share is investing kr2.13 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.37%.
More news about ELKEM.
2. IMCD (IMCD.AS)
2.15% Forward Dividend Yield and 17.66% Return On Equity
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers bioactives, biocides, chelates, functional additives, rheology modifiers, silicones, solubilisers, and solvents; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, binders, corrosion inhibitors, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, IMCD has a trailing twelve months EPS of €5.06.
PE Ratio
IMCD has a trailing twelve months price to earnings ratio of 22.05. Meaning, the purchaser of the share is investing €22.05 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.66%.
Yearly Top and Bottom Value
IMCD’s stock is valued at €111.55 at 07:30 EST, way under its 52-week high of €156.70 and higher than its 52-week low of €109.45.
More news about IMCD.
